Literature DB >> 26420065

PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells.

Haibo Han1, Yantao Du1, Wei Zhao1, Sheng Li1, Dongji Chen1, Jing Zhang2, Jiang Liu2, Zhenhe Suo3, Xiuwu Bian4, Baocai Xing5, Zhiqian Zhang1.   

Abstract

Tumour-initiating cells (TICs) are advocated to constitute the sustaining force to maintain and renew fully established malignancy; however, the molecular mechanisms responsible for these properties are elusive. We previously demonstrated that voltage-gated calcium channel α2δ1 subunit marks hepatocellular carcinoma (HCC) TICs. Here we confirm directly that α2δ1 is a HCC TIC surface marker, and identify let-7c, miR-200b, miR-222 and miR-424 as suppressors of α2δ1(+) HCC TICs. Interestingly, all the four miRNAs synergistically target PBX3, which is sufficient and necessary for the acquisition and maintenance of TIC properties. Moreover, PBX3 drives an essential transcriptional programme, activating the expression of genes critical for HCC TIC stemness including CACNA2D1, EpCAM, SOX2 and NOTCH3. In addition, the expression of CACNA2D1 and PBX3 mRNA is predictive of poor prognosis for HCC patients. Collectively, our study identifies an essential signalling pathway that controls the switch of HCC TIC phenotypes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26420065     DOI: 10.1038/ncomms9271

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  64 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

3.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

4.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

5.  Mapping and quantifying mammalian transcriptomes by RNA-Seq.

Authors:  Ali Mortazavi; Brian A Williams; Kenneth McCue; Lorian Schaeffer; Barbara Wold
Journal:  Nat Methods       Date:  2008-05-30       Impact factor: 28.547

6.  The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.

Authors:  M Fareh; L Turchi; V Virolle; D Debruyne; F Almairac; S de-la-Forest Divonne; P Paquis; O Preynat-Seauve; K-H Krause; H Chneiweiss; T Virolle
Journal:  Cell Death Differ       Date:  2011-07-01       Impact factor: 15.828

Review 7.  The cancer stem cell: premises, promises and challenges.

Authors:  Hans Clevers
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

8.  The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

Authors:  Xiao-Lan Xu; Bao-Cai Xing; Hai-Bo Han; Wei Zhao; Mei-Hao Hu; Zuo-Liang Xu; Ji-You Li; Yong Xie; Jun Gu; Yu Wang; Zhi-Qian Zhang
Journal:  Carcinogenesis       Date:  2009-11-06       Impact factor: 4.944

9.  A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Joyce Huan Chen; Lihua Wang; Jewell Walters; Yong Jun Shin; Julian P Goerger; Jian Sun; Mavee Witherspoon; Nikolai Rakhilin; Jiahe Li; Herman Yang; Jeff Milsom; Sang Lee; Warren Zipfel; Moonsoo M Jin; Zeynep H Gümüş; Steven M Lipkin; Xiling Shen
Journal:  Cell Stem Cell       Date:  2013-05-02       Impact factor: 24.633

10.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

View more
  35 in total

1.  MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3.

Authors:  Xiupeng Xu; Zhongyuan Bao; Yinlong Liu; Jing Ji; Ning Liu
Journal:  Cell Mol Neurobiol       Date:  2017-01-25       Impact factor: 5.046

2.  Prognostic and clinicopathological significance of Cacna2d1 expression in epithelial ovarian cancers: a retrospective study.

Authors:  Dandan Yu; Ruth Holm; Mariusz Adam Goscinski; Claes G Trope; Jahn M Nesland; Zhenhe Suo
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

3.  Prediction of single-cell gene expression for transcription factor analysis.

Authors:  Fatemeh Behjati Ardakani; Kathrin Kattler; Tobias Heinen; Florian Schmidt; David Feuerborn; Gilles Gasparoni; Konstantin Lepikhov; Patrick Nell; Jan Hengstler; Jörn Walter; Marcel H Schulz
Journal:  Gigascience       Date:  2020-10-30       Impact factor: 6.524

4.  Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo.

Authors:  Xiupeng Xu; Ning Cai; Zhongyuan Bao; Yongping You; Jing Ji; Ning Liu
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

5.  HBO1 overexpression is important for hepatocellular carcinoma cell growth.

Authors:  Wenhui Zhong; Heping Liu; Li Deng; Guohua Chen; Yubin Liu
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

6.  Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer.

Authors:  Yuanyuan Ma; Xiaodan Yang; Wei Zhao; Yue Yang; Zhiqian Zhang
Journal:  Cell Death Dis       Date:  2021-03-11       Impact factor: 8.469

Review 7.  Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.

Authors:  Terence Kin-Wah Lee; Xin-Yuan Guan; Stephanie Ma
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-09       Impact factor: 46.802

8.  Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness.

Authors:  Chi-Feng Tseng; Li-Tzong Chen; Horng-Dar Wang; Yi-Hong Liu; Shine-Gwo Shiah
Journal:  Cancer Sci       Date:  2022-03-15       Impact factor: 6.518

9.  Whole-Transcriptome Analysis of LncRNAs Mediated ceRNA Regulation in Granulosa Cells Isolated From Healthy and Atresia Follicles of Chinese Buffalo.

Authors:  Yu Pan; Sufang Yang; Juanru Cheng; Qiao Lv; Qinghua Xing; Ruimen Zhang; Jingyuan Liang; Deshun Shi; Yanfei Deng
Journal:  Front Vet Sci       Date:  2021-07-14

10.  Influence of cross-disorder analyses on the diagnostic criteria of mental illnesses.

Authors:  Meiti Wang; Donghong Cui
Journal:  Shanghai Arch Psychiatry       Date:  2016-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.